Introduction to Research Theme: Dementia
People with Down syndrome represent the world’s largest population with a genetic predisposition to Alzheimer’s disease (AD). Everyone with Down syndrome has the neuropathological hallmarks of AD by age 40, and a cumulative risk of 88% of developing Alzheimer-type dementia (DS-AD) by age 65. The most common cause of Down syndrome is an extra copy of chromosome 21 – trisomy 21. Amyloid precursor protein (APP) is produced by chromosome 21; consequently, people with Down syndrome overexpress APP, leading to the development of amyloid plaques – the hallmark of AD.
While people with an intellectual disability from other aetiologies don’t have a genetic risk for Alzheimer’s disease, the risk for developing dementia is approximately 5 times higher than in the general population.
Diagnosis and assessment for dementia for people with an intellectual disability is challenging because of pre-existing level of intellectual disability and there is no standardised assessment protocol.
The research completed by the Centre
Advances standardization and validation of assessment instruments.
Examines biomarkers of Alzheimer’s Disease in people with Down syndrome.
Offers practical strategies for care, and design of living environments.
Builds valuable information on improving service provision and quality of life for people with Down syndrome and dementia.
Promotes future planning and services provider strategy development for those with dementia and Down syndrome.
Ensures person-centred and dementia appropriate end of life care
Projects Under the Dementia Theme
IDS-TILDA
PREVENT Dementia -DS
Best Practice Post-Diagnostic Guidelines for Dementia for People with an Intellectual Disability
Mortality and Dementia in People with Down syndrome
Supporting Brain Health in People with Down syndrome in South Africa
Longitudinal Research in AVISTA
Cognitive Stimulation Therapy in People with Intellectual Disability and Dementia
Collaborations and Impact
Global Brain Health
Horizon 21 European Down syndrome Consortium
Dementia Trials Ireland
National Task Group in Intellectual Disabilities and Dementia
Down syndrome Ireland
Dementia Team
- Dr. Eimear McGlinchey Theme Lead, Asst. Prof. in Intellectual Disability
- Prof. Mary McCarron PI to IDS-TILDA
- Prof. Philip McCallion Senior Academic Advisor to TCAID
- Evelyn Reilly CNS in Dementia
- Prof. Sean Kennelly Clinical Director NIDMS
- Miriam Fitzpatrick Research Assistant
- Marianne Fallon PhD Student
- Pavithra PhD Student